LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM PHARMA
02 1INSMED
03 1IPSEN INC
04 1TARGACEPT
01 2INJECTABLE;SUBCUTANEOUS
02 2TABLET;ORAL
01 1DISCN
02 1RX
03 2Blank
01 1INCRELEX
02 1INVERSINE
03 1IPLEX
04 1MECAMYLAMINE HYDROCHLORIDE
01 1No
02 1Yes
03 2Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
RLD : No
TE Code :
Brand Name : MECAMYLAMINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Approval Date : 2013-03-19
Application Number : 204054
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : INVERSINE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 10251
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD :
TE Code :
MECASERMIN RINFABATE RECOMBINANT
Brand Name : IPLEX
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 36MG/0.6ML
Approval Date :
Application Number : 21884
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Brand Name : INCRELEX
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 40MG/4ML (10MG/ML)
Approval Date :
Application Number : 21839
RX/OTC/DISCN :
RLD :
TE Code :
LOOKING FOR A SUPPLIER?
